Literature DB >> 1212662

A colon tumor model for anticancer agent evaluation.

D P Griswold, T H Corbett.   

Abstract

Colon tumors of mice were induced with 1, 2-dimethylhydrazine, N-nitroso-N-methylurethane, methylnitrosourea, and 4-methyl-N'-nitro-N-nitrosoguanidine. Of 82 transplantation attempts, four were successful, and the four tumors have been maintained as distinct tumor lines by subcutaneous transplantation. The tumors graded from II, adenocarcinoma, to IV, undifferentiated carcinoma. Volume-doubling times varied over a three-fold range, and metastatic potential ranged from 5 to about 100%. The tumors responded to treatment with some of the same agents found to be active in man. These included cyclophosphamide, 5-fluorouracil, and certain nitrosoureas. Preliminary evidence suggests that these tumor lines may be useful as experimental models.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1212662     DOI: 10.1002/1097-0142(197512)36:6<2441::aid-cncr2820360627>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

Authors:  Nuh N Rahbari; Dmitriy Kedrin; Joao Incio; Hao Liu; William W Ho; Hadi T Nia; Christina M Edrich; Keehoon Jung; Julien Daubriac; Ivy Chen; Takahiro Heishi; John D Martin; Yuhui Huang; Nir Maimon; Christoph Reissfelder; Jurgen Weitz; Yves Boucher; Jeffrey W Clark; Alan J Grodzinsky; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Sci Transl Med       Date:  2016-10-12       Impact factor: 17.956

2.  Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope.

Authors:  Adam E Snook; Trevor R Baybutt; Terry Hyslop; Scott A Waldman
Journal:  Hum Gene Ther Methods       Date:  2016-12       Impact factor: 2.396

3.  Synergistic antitumor activity of interleukin-2 and cimetidine against syngeneic murine tumor.

Authors:  I Nakajima; T M Chu
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

4.  Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.

Authors:  Charles S Tannenbaum; Patricia A Rayman; Paul G Pavicic; Jin Sub Kim; Wei Wei; Alexandra Polefko; Wesley Wallace; Brian I Rini; Gareth Morris-Stiff; Daniela S Allende; Thomas Hamilton; James H Finke; C Marcela Diaz-Montero
Journal:  Cancer Immunol Res       Date:  2019-08-22       Impact factor: 11.151

5.  Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Authors:  John P Dougherty; Brian S Wolff; Mary J Cullen; Leorey N Saligan; Marvin C Gershengorn
Journal:  Pharmacol Res       Date:  2017-07-15       Impact factor: 7.658

6.  Colchicine inhibits pressure-induced tumor cell implantation within surgical wounds and enhances tumor-free survival in mice.

Authors:  David H Craig; Cheri R Owen; William C Conway; Mary F Walsh; Christina Downey; Marc D Basson
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

7.  Chemotherapy studies in autochthonous rat tumors intestinal cancer.

Authors:  F Sych; M Habs; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24

8.  Adjuvant chemotherapy in a new metastasizing caecum tumor model.

Authors:  F A Zoetmulder; A Zwaveling
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

9.  Growth characteristics and metastatic potential of seven intestinal carcinoma lines serially passaged in syngeneic rats.

Authors:  M S Martin; F Martin; M F Michel; A Hammann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

10.  The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

Authors:  A Y Huang; P H Gulden; A S Woods; M C Thomas; C D Tong; W Wang; V H Engelhard; G Pasternack; R Cotter; D Hunt; D M Pardoll; E M Jaffee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.